Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6151 followers
Created: 2025-07-25 11:53:23 UTC

Genpharmasec Expands Portfolio with XX% Stake in Derren Healthcare 🚀 | MCap XXXXXX Cr

- Genpharmasec completed a XX% stake acquisition in Derren Healthcare (DHPL) on 25th July 2025.
- Acquisition cost: ₹34.15 crores (cash consideration).
- DHPL specializes in generics & innovative finished formulations, with operations across India.
- DHPL’s FY25 turnover: ₹858.82 lacs (FY24: ₹627.69 lacs, FY23: ₹70.24 lacs).
- Authorized share capital: ₹7.5 crores; paid-up capital: ₹7.4 crores.
- No related-party transactions or regulatory approvals required.

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

![](https://pbs.twimg.com/media/Gws4NNHakAAs97F.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948713187844477337/c:line.svg)

**Related Topics**
[india](/topic/india)
[acquisition](/topic/acquisition)
[mcap](/topic/mcap)
[coins healthcare](/topic/coins-healthcare)
[investment](/topic/investment)
[$issc](/topic/$issc)

[Post Link](https://x.com/_Investor_Feed_/status/1948713187844477337)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Investor_Feed Avatar Investor Feed @Investor_Feed on x 6151 followers Created: 2025-07-25 11:53:23 UTC

Genpharmasec Expands Portfolio with XX% Stake in Derren Healthcare 🚀 | MCap XXXXXX Cr

  • Genpharmasec completed a XX% stake acquisition in Derren Healthcare (DHPL) on 25th July 2025.
  • Acquisition cost: ₹34.15 crores (cash consideration).
  • DHPL specializes in generics & innovative finished formulations, with operations across India.
  • DHPL’s FY25 turnover: ₹858.82 lacs (FY24: ₹627.69 lacs, FY23: ₹70.24 lacs).
  • Authorized share capital: ₹7.5 crores; paid-up capital: ₹7.4 crores.
  • No related-party transactions or regulatory approvals required.

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

XXX engagements

Engagements Line Chart

Related Topics india acquisition mcap coins healthcare investment $issc

Post Link

post/tweet::1948713187844477337
/post/tweet::1948713187844477337